Private Equity
4 min read · 08 January 2018
2 min read · 08 January 2018
Auburn, Alabama-based Vitruvias Therapeutics Inc, a maker of generic drugs, has closed $11.5 million in financing. JW Asset Management LLC and Perceptive Advisors led the round.
1 min read · 08 January 2018
Leading Pharma LLC, a maker of generic drugs, has raised $40 million in funding. Signet Healthcare Partners led the round with participation from other backers that included Crestline Investors and Cane Investment Partners. In conjunction with the funding, Nikhil Puri, a managing director at Signet Healthcare Partners and Chris Semple, a managing director at Crestline Investors, will join the board of directors of Leading Pharma's parent company.
1 min read · 08 January 2018
SV Health Investors has promoted Michael Balmuth to managing partner and Houman Ashrafian to partner. Balmuth joined SV in 2014 and previously worked at Edison Partners where he was a general partner and head of the firm’s healthcare information technology practice. Ashrafian joined SV in 2016.
3 min read · 08 January 2018
Los Angeles-based Neural Analytics, a medical device company focused on measuring, diagnosing and tracking brain health, has secured $15 million in Series B funding. Alpha Edison led the round.
1 min read · 08 January 2018
Canadian private equity firm Clairvest Group has sold its interest in Wellington Financial, a Toronto-based specialty finance firm, to the Canadian Imperial Bank of Commerce (CIBC). No financial terms were disclosed for the deal, which includes the loan assets of Wellington Financial Fund V, which raised $300 million in 2015. Wellington was launched in 2000 by Clairvest and Mark McQueen, the firm's president and CEO, to provide growth-oriented debt to Canadian and U.S. technology companies, many of them venture-backed. Wellington's team will join the newly created CIBC Innovation Banking, which provides strategic advice and funding to innovative clients across North America.
3 min read · 08 January 2018
Alexandria Venture Investments, a venture arm of Alexandria Real Estate Equities Inc, an urban office REIT, has launched Alexandria Seed Capital Platform, which will focus on promising life science startups. Alexandria Venture Investments will lead Alexandria Seed Capital Platform whose advisory board is comprised of venture capital executives from Accelerator Life Science Partners, ARCH Venture Partners, Eli Lilly and Company, Pfizer and Roche.
5 min read · 08 January 2018
Intuity Medical Inc, a developer of technologies for diabetes management, has raised $70 million in funding. The investors included Accuitive Medical Ventures, Investor Growth Capital, KCK Group, Luther King Capital Management, PTV Healthcare Capital, U.S. Venture Partners, Versant Ventures and Hercules Capital.
1 min read · 08 January 2018
UK-based Storm Therapeutics, which focuses on developing small molecule drugs that target RNA-modifying enzymes, has raised 4 million pounds in funding. The investor was Taiho Ventures LLC. In conjunction with the funding, Sakae Asanuma, president of Taiho Ventures, joins Storm Therapeutics' board of directors.
1 min read · 08 January 2018
